330 related articles for article (PubMed ID: 18248345)
21. Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults.
Chattopadhyay A; Caplan DJ; Slade GD; Shugars DC; Tien HC; Patton LL
Community Dent Oral Epidemiol; 2005 Feb; 33(1):35-44. PubMed ID: 15642045
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of oral lesions and periodontal diseases in HIV-infected patients on antiretroviral therapy.
Kroidl A; Schaeben A; Oette M; Wettstein M; Herfordt A; Häussinger D
Eur J Med Res; 2005 Oct; 10(10):448-53. PubMed ID: 16287607
[TBL] [Abstract][Full Text] [Related]
23. Oral lesions and immune reconstitution syndrome in HIV+/AIDS patients receiving highly active antiretroviral therapy. Epidemiological evidence.
Gaitan Cepeda LA; Ceballos Salobreña A; López Ortega K; Arzate Mora N; Jiménez Soriano Y
Med Oral Patol Oral Cir Bucal; 2008 Feb; 13(2):E85-93. PubMed ID: 18223535
[TBL] [Abstract][Full Text] [Related]
24. Changes in the pattern of oral lesions associated with HIV infection: implications for dentists.
Sroussi HY; Epstein JB
J Can Dent Assoc; 2007 Dec; 73(10):949-52. PubMed ID: 18275698
[TBL] [Abstract][Full Text] [Related]
25. The prevalence of HIV associated oral lesions among adults in the era of HAART.
Mthethwa SR; Wanjau J; Chabikuli N
SADJ; 2013 Sep; 68(8):364-71. PubMed ID: 24660404
[TBL] [Abstract][Full Text] [Related]
26. Patterns of skin manifestations and their relationships with CD4 counts among HIV/AIDS patients in Cameroon.
Josephine M; Issac E; George A; Ngole M; Albert SE
Int J Dermatol; 2006 Mar; 45(3):280-4. PubMed ID: 16533229
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India.
Shah SU; Kerkar SP; Pazare AR
Br J Ophthalmol; 2009 Jan; 93(1):88-90. PubMed ID: 18952644
[TBL] [Abstract][Full Text] [Related]
28. Orofacial lesions in 126 newly diagnosed HIV/AIDS patients seen at the University College Hospital, Ibadan.
Okoje VN; Obiechina AE; Aken'Ova YA
Afr J Med Med Sci; 2006 Mar; 35(1):97-101. PubMed ID: 17209335
[TBL] [Abstract][Full Text] [Related]
29. Brazilian HIV-infected population: assessment of the needs of endodontic treatment in the post-highly active antiretroviral therapy era.
de Brito LC; da Rosa MA; Lopes VS; e Ferreira EF; Vieira LQ; Sobrinho AP
J Endod; 2009 Sep; 35(9):1178-81. PubMed ID: 19720212
[TBL] [Abstract][Full Text] [Related]
30. Oral white patches in a national sample of medical HIV patients in the era of HAART.
Marcus M; Maida CA; Freed JR; Younai F; Coulter ID; Der-Martirosian C; Liu H; Freed B; Guzmán-Becerra N; Shapiro M
Community Dent Oral Epidemiol; 2005 Apr; 33(2):99-106. PubMed ID: 15725172
[TBL] [Abstract][Full Text] [Related]
31. Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era.
dos Santos Pinheiro R; França TT; Ribeiro CM; Leão JC; de Souza IP; Castro GF
J Oral Pathol Med; 2009 Sep; 38(8):613-22. PubMed ID: 19614862
[TBL] [Abstract][Full Text] [Related]
32. Oral manifestations of HIV infection: a Panamerican perspective.
Gillespie GM; Mariño R
J Oral Pathol Med; 1993 Jan; 22(1):2-7. PubMed ID: 7678293
[TBL] [Abstract][Full Text] [Related]
33. Oral lesions in HIV-positive patients in Georgia.
Kakabadze T; Rukhadze N; Mshvidobadze K; Lomtadze M; Kandelaki G
Georgian Med News; 2008 Dec; (165):60-5. PubMed ID: 19124919
[TBL] [Abstract][Full Text] [Related]
34. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.
Jevtović Dj; Vanovac V; Veselinović M; Salemović D; Ranin J; Stefanova E
Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516
[TBL] [Abstract][Full Text] [Related]
35. Oral health management of 97 patients living with HIV/AIDS in Ribeirão Preto, São Paulo, Brazil.
Silva DC; Lourenço AG; Ribeiro AE; Machado AA; Komesu MC; Motta AC
Braz Oral Res; 2015; 29():1-6. PubMed ID: 26313345
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and risk indicators of oral mucosal lesions in an urban population from South Brazil.
Carrard V; Haas A; Rados P; Filho M; Oppermann R; Albandar J; Susin C
Oral Dis; 2011 Mar; 17(2):171-9. PubMed ID: 20659262
[TBL] [Abstract][Full Text] [Related]
37. Pattern of head and neck malignant neoplasms in HIV-infected patients in Kenya.
Butt FM; Chindia ML; Rana F; Machigo FG
Int J Oral Maxillofac Surg; 2008 Oct; 37(10):907-11. PubMed ID: 18783921
[TBL] [Abstract][Full Text] [Related]
38. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience.
Zancanaro PC; McGirt LY; Mamelak AJ; Nguyen RH; Martins CR
J Am Acad Dermatol; 2006 Apr; 54(4):581-8. PubMed ID: 16546578
[TBL] [Abstract][Full Text] [Related]
40. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
